West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-07-24T12:08:48.000Z","dateModified":"2026-07-24T12:10:53.000Z","description":"West Pharmaceutical Services beats Q2 earnings, raises FY guidance, and sees biologics-driven margin gains. 2Q26 adjusted EPS came in at $2.37, a $0.29 beat over the consensus, with revenue managing to hit $872.3 million.
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-07-24T12:08:48.000Z","dateModified":"2026-07-24T12:10:53.000Z","description":"West Pharmaceutical Services beats Q2 earnings, raises FY guidance,
- ▪2Q26 adjusted EPS came in at $2.37, a $0.29 beat over the consensus, with revenue managing to hit $872.3 million.
Seeking Alpha files mainly under finance. We currently carry 6,049 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Earnings Analysis","item":"https://seekingalpha.com/earnings/earnings-analysis"},{"@type":"ListItem","position":3,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4925242-west-pharma-delivers-another-beat-but-the-real-story-is-the-mix-shift"},"author":{"@type":"Person","name":"Petri Dish…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
